The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies
Johanna Balslev Andersen(University of Copenhagen), Gilles Edan(Centre National de la Recherche Scientifique), Karen Ingrid Schreiber(Copenhagen University Hospital), Diana Ferraro(Azienda Ospedaliero-Universitaria di Modena), Murat Terzi(Ondokuz Mayıs University), Sifat Sharmin(The Royal Melbourne Hospital), Franco Granella(University of Parma), Jeannette Lechner‐Scott(John Hunter Hospital), Michael Broksgaard Jensen(University of Southern Denmark), María Trojano(University of Bari Aldo Moro), Nils Koch‐Henriksen(Aarhus University Hospital), Dana Horáková(Charles University), Francois Grand’ Maison, Bassem Yamout(American University of Beirut Medical Center), Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Marco Onofrj(University of Chieti-Pescara), Sara Eichau(Hospital Universitario Virgen Macarena), Romain Casey(Université Claude Bernard Lyon 1), Julie Prévost(Cegep de Saint Jerome), Raed Alroughani(Amiri Hospital), Cavit Boz(Farabi Hastanesi), Pierre Duquette(Centre Hospitalier de l’Université de Montréal), Pamela McCombe(The University of Queensland), Vahid Shaygannejad(Isfahan University of Medical Sciences), Peter Vestergaard Rasmussen(Aarhus University Hospital), Mark Slee(Flinders University), Stephan Bramow(Copenhagen University Hospital), Pierre Grammond(Centre intégré de santé et de services sociaux de Chaudière-Appalaches), Per Soelberg Sørensen(University of Copenhagen), Recai Türkoğlu(Haydarpaşa Numune Eğitim ve Araştırma Hastanesi), Daniele Spitaleri(Azienda Ospedaliera S.Giuseppe Moscati), Francesco Patti(University of Catania), Rana Karabudak(Hacettepe University), Alexandre Prat(Université de Montréal), Eva Havrdová(Charles University), Jette Lautrup Frederiksen(University of Copenhagen), Patrizia Sola(Azienda Ospedaliero-Universitaria di Modena), Tünde Csépány(University of Debrecen), Mathilde Lefort(Inserm), Serkan Özakbaş(İzmir University of Economics), Claudio Solaro(Rina Services (Italy)), Steve Vucic(Westmead Hospital), Bart Van Wijmeersch(Hasselt University), Marc Girard(Université de Montréal), Marc Debouverie(Centre Hospitalier Régional et Universitaire de Nancy), Olga Skibina(Box Hill Hospital), Claudia C Hilt Christensen(Aalborg University Hospital), Henrik Kahr Mathiesen(Gentofte Hospital), Guillermo Izquierdo(Hospital Universitario Virgen Macarena), Finn Sellebjerg(Danish Multiple Sclerosis Center)
Cited by 12
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
The Blood–Brain Barrier
|Cold Spring Harbor Perspectives in Biology|2015|3.2k